Alzheimer’s is the most common form of dementia and affects around 850,000 people living in the UK, but a new drug aims to help patients in the early stages.
A “groundbreaking” drug that could slow down Alzheimer’s disease may soon be available to millions.
US pharmaceutical giant Biogen is looking to get approval to make the drug readily available.
Successful medical trials showed significant results for using the drug - known as aducanumab.
Biogen said results from more than 3,000 people with Alzheimer’s showed the drug led to a significant slowing of the disease’s progression.
Analysis of the trial data found that patients using the drug experienced benefits in memory, orientation, language and everyday living skills, such as shopping.
If it's approved, Biogen says the drug would be the first treatment to “reduce the clinical decline” of patients in the early stages - a significant breakthrough in terms of dementia.
Aducanumab is the first of its kind. Currently, there are only drugs that can help with symptoms.
The approval process could take up to two years but if it’s successful, the company hopes to initially offer the drug to the patients enrolled in the clinical studies.
The drug works by targeting a protein called amyloid, which forms abnormal deposits the brains of people with Alzheimer's.
Hilary Evans, from Alzheimer's Research UK, said: "People affected by Alzheimer's have waited a long time for a life-changing new treatment and this exciting announcement offers new hope that one could be in sight.
"Taking another look at aducanumab is a positive step for all those who took part in the clinical trials and the worldwide dementia research community.
"As more data emerges, we hope it will spark global discussions about the next steps for delivering much-needed treatments into people's hands."
The news comes as a slight surprise, due to the fact that Biogen stopped two studies of the drug earlier this year. This is because partial results suggested it was not likely to be successful.
Biogen have since said the findings of the initial analysis were "incorrect".
Prince Harry and Meghan's ITV air date for Oprah interview confirmed
The air date of Prince Harry and the Duchess of Sussex's interview with Oprah has been announced
By Laura Harman •
Why we need to spring clean like Drew Barrymore
Drew Barrymore has opened up on the sense of control she feels by decluttering in this way...
By Selina Maycock •
What is tinnitus and how can it affect your health?
Plus, treatments to alleviate tinnitus symptoms.
By Amy Hunt •
Fitness for women – 5 ways to boost motivation and enjoy exercise
Our health guru, Annie Deadman, makes fitness for women achievable, fun and simple...
By Lucy Gornall •
An expert guide to cancerous moles and the skin cancer signs that should raise your suspicions
Itchy, raised or bleeding moles? Spotting the signs that could save your life…
By Faye M Smith •
Yoga for weight loss - why it works, when to practice and the three moves you need to know about
Want to stretch and slim? Then it's time to try yoga for weight loss...
By Rose Goodman •
How to be happy in nature – boost your mood instantly by going outside
Learning how to be happy is easier than you think. Try these simple tips to stay mentally strong
By Ali Horsfall •
Research reveals that 14.5% of women feel menopause is affecting their sex lives
New research has revealed that 14.5% of women feel that menopause is affecting their sex lives
By Aleesha Badkar •
Your most Googled sleep problems solved: from insomnia and night sweats to the best positions to stop pain
Sleep problems wreaking havoc with your wellbeing? We asked the experts the questions that are keeping you up at night...
By Rose Goodman •
The best sleep teas for relaxing at bedtime
Sleep teas can help relax your body and mind for a better night's rest
By Aleesha Badkar •